¼¼°èÀÇ Èñ±ÍÁúȯ Áø´Ü ½ÃÀå : Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ - Áúº´ À¯Çüº°, Á¦Ç° À¯Çüº°, »ùÇà À¯Çüº°, ±â¼úº°, Å×½ºÆ®º°, ¿¬·ÉÃþº°, Ư¼º À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÎ¹® ¿¹Ãø(2024-2032³â)
Global Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type; By Product Type; By Sample Type; By Technology; By Test; By Age Group; By Trait Type; By End-User; By Region; Segment Forecast, 2024 - 2032
»óǰÄÚµå : 1504935
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2024³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 118 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 6,149,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,596,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 9,043,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ Èñ±ÍÁúȯ Áø´Ü ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 889¾ï 6,927¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

Èñ±ÍÁúȯ Áø´Ü ½ÃÀåÀº ±Þ¼ÓÇÑ ±â¼ú Áøº¸¿Í ±Ô¸ðÀÇ °æÁ¦¿¡ ÀÇÇØ ÃËÁøµÇ´Â °Ô³ð ½ÃÄö½ÌÀÇ ÀÔ¼ö ¿ëÀ̼º°ú °¡°Ý »ó½ÂÀ̶ó´Â ±â¼ú Çõ½Å¿¡ °ßÀÎµÇ¾î °­·ÂÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ½ÃÄö½Ì ºñ¿ëÀÌ °è¼Ó ³·¾ÆÁö°í ºÐ¼® ¼Óµµ°¡ Çâ»óµÊ¿¡ µû¶ó °Ô³ð °Ë»ç°¡ ´õ ³Î¸® »ç¿ëµÇ°í °Ç°­ °ü¸® °ø±ÞÀÚ´Â Èñ±ÍÁúȯÀÌ ÀǽɵǴ ȯÀÚ¿¡°Ô Á¾ÇÕÀûÀÎ À¯ÀüÀÚ Æò°¡¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. Çß½À´Ï´Ù.

±×·¯³ª À̸¦ À§Çؼ­´Â Èñ±ÍÁúȯÀÇ Æ¯Á¤¿¡ ƯȭµÈ »õ·Î¿î °Ë»ç¹ý, ¹ÙÀÌ¿À¸¶Ä¿, ±â¼úÀÇ ¹ß°ß°ú °ËÁõÀÌ ÇÊ¿äÇÕ´Ï´Ù. R&D ÅõÀÚ´Â ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ¿© º¸´Ù Á¤È®Çϰí È¿À²ÀûÀÌ¸ç ºñ¿ë È¿À²ÀûÀÎ °Ë»ç ¼Ö·ç¼ÇÀ» °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. Çмú°è, Á¦¾à ȸ»ç, »ý¸í °øÇÐ ±â¾÷ÀÇ Çù·ÂÀº °úÇÐÀû ÀÌÇØ¸¦ ÃßÁøÇÏ°í ¹ß°ßÀ» ½Ç¿ëÀûÀÎ Áø´Ü µµ±¸·Î ÀüȯÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

Èñ±ÍÁúȯÀ» ´ë»óÀ¸·Î ÇÏ´Â Ä¡·á³ª Áø´Ü Åø ½ÃÀå ±Ô¸ð°¡ ÇÑÁ¤µÇ¾î ÀÖ´Â °Íµµ, °íºñ¿ëÀÇ ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ´Üü, Á¤Ã¥ ÀÔ¾ÈÀÚ, ÀÇ·á ÀÌÇØ °ü°èÀÚ´Â Èñ±ÍÁúȯÀÇ °æÁ¦Àû ºÎ´ã¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̰í, ÀÌȯÀÚ¸¦ À§ÇÑ Àú·ÅÇÑ Áø´Ü °Ë»ç³ª Ä¡·á¿¡ÀÇ ¾×¼¼½º¸¦ °³¼±Çϱâ À§ÇÑ ´ëÃ¥À» ½Ç½ÃÇϱâ À§ÇØ ³ë·Â ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼úÀÇ Áøº¸¿Í °øµ¿ ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê´Â ¹Ì·¡¿¡ Èñ±ÍÁúȯ Áø´ÜÀÇ ºñ¿ë Àý°¨°ú È¿À²È­·Î À̾îÁú °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ Èñ±ÍÁúȯ Áø´Ü ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Ç÷¾× ¹× Á¾¾ç Áúȯ ºÐ¾ß´Â Èñ¼ÒÇÑ Ç÷¾× ÁúȯÀ̳ª Á¾¾ç ÁúȯÀ» Á¤È®ÇÏ°í ½Å¼ÓÇÏ°Ô °ËÃâÇØ, Á¶±â °³ÀÔÀ̳ª ÁÖ¹®Á¦ÀÇ Ä¡·á ¾îÇÁ·ÎÄ¡¿¡ ¿¬°áÇϰí Àֱ⠶§¹®¿¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.

ŰƮ ¹× ½Ã¾à ºÎ¼­´Â ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÏ´Â Èñ±ÍÁúȯ °ËÃâ ±â¼úÀÇ ¹ßÀüÀ¸·Î ½ÃÀåÀ» ¼®±ÇÇÏ°í °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­´Â ÃÖ÷´Ü ÀÎÇÁ¶ó, ÷´Ü ±â¼ú ¹× Áø´ÜÀ» À§ÇÑ ¼÷·ÃµÈ ÀηÂÀ¸·Î ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.

Èñ±Í Áúº´À» Á¤È®ÇÏ°Ô ½Äº°Çϰí Áø´ÜÇÒ ¼ö ÀÖ´Â Àü¹® Áø´Ü ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Áø´Ü ½ÇÇè½Ç ºÎ¼­´Â ¿¹»ó ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì´Â Èñ±ÍÁúȯÀÇ Áø´Ü°ú Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â À¯ÀüÀÚ °Ë»ç¿Í Á¤¹ÐÀÇ·áÀÇ Áøº¸·Î ¾÷°è¸¦ ¼±µµÇÏ°í ½ÃÀå ¼öÀÍ Á¡À¯À²ÀÇ ´ëºÎºÐÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÀÌÇØ°ü°èÀÚ

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå Á¶»ç ¹æ¹ý

Á¦5Àå ¼¼°èÀÇ Èñ±ÍÁúȯ Áø´Ü ½ÃÀå ÀλçÀÌÆ®

Á¦6Àå ¼¼°èÀÇ Èñ±ÍÁúȯ Áø´Ü ½ÃÀå : Áúº´ À¯Çüº°

Á¦7Àå ¼¼°èÀÇ Èñ¼ÒÁúȯ Áø´Ü ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦8Àå ¼¼°èÀÇ Èñ¼ÒÁúȯ Áø´Ü ½ÃÀå : »ùÇà À¯Çüº°

Á¦9Àå ¼¼°èÀÇ Èñ¼ÒÁúȯ Áø´Ü ½ÃÀå : ±â¼úº°

Á¦10Àå ¼¼°èÀÇ Èñ¼ÒÁúȯ Áø´Ü ½ÃÀå : °Ë»çº°

Á¦11Àå ¼¼°èÀÇ Èñ¼ÒÁúȯ Áø´Ü ½ÃÀå : ¿¬·ÉÃþº°

Á¦12Àå ¼¼°èÀÇ Èñ¼ÒÁúȯ Áø´Ü ½ÃÀå : Ư¼º À¯Çüº°

Á¦13Àå ¼¼°èÀÇ Èñ¼ÒÁúȯ Áø´Ü ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦14Àå ¼¼°èÀÇ Èñ±ÍÁúȯ Áø´Ü ½ÃÀå :Áö¿ª

Á¦15Àå °æÀï ±¸µµ

Á¦16Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global rare disease diagnostics market size is expected to reach USD 88,969.27 million by 2032, according to a new study by Polaris Market Research. The report "Global Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type; By Product Type; By Sample Type; By Technology; By Test; By Age Group; By Trait Type; By End-User; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rare disease diagnostics market is experiencing robust growth, driven by innovation is the increasing accessibility and affordability of genomic sequencing, facilitated by rapid technological advancements and economies of scale. As the cost of sequencing continues to decline and the speed of analysis improves, genomic testing has become more widely available, enabling healthcare providers to offer comprehensive genetic evaluations to patients with suspected rare diseases.

However, this involves the discovery and validation of novel testing methods, biomarkers, and technologies tailored for identifying rare diseases. Investments in R&D drive innovation, enabling the development of more accurate, efficient, and cost-effective testing solutions. Collaboration between academia, pharmaceutical companies, and biotech firms is crucial in advancing scientific understanding and translating discoveries into practical diagnostic tools.

The limited market size for treatments and diagnostic tools targeting rare diseases also contributes to their high cost. Advocacy organizations, policymakers, and healthcare stakeholders are working to raise awareness of the economic burden of rare diseases and implement measures to improve access to affordable diagnostic testing and treatments for affected individuals. Additionally, advancements in technology and collaborative research initiatives hold promise for driving down costs and improving the efficiency of rare disease diagnosis in the future.

Global Rare Disease Diagnostics Market Report Highlights

The Hematology and Oncology disease segment dominated the market owing to the precise and prompt detection of rare blood and oncological conditions, which led to early intervention and tailored treatment approaches.

The Kits and Reagents segment dominated and is anticipated to grow at the fastest CAGR owing to advancements in the detection of rare diseases, which enable quicker and more precise diagnosis.

The Research Laboratories and Cros segment dominated the market owing to cutting-edge infrastructure, advanced technologies, and skilled personnel for diagnostic purposes.

The Diagnostics Laboratories segment is expected to witness the highest CAGR over the anticipated period due to a rise in demand for specialized diagnostic services that can accurately identify and diagnose rare diseases.

North America led the industry and accounted for a majority of market revenue share owing to the progress made in genetic testing and precision medicine, which play crucial roles in diagnosing and treating rare conditions.

The global key market players include CENTOGENE N.V., F. Hoffmann-La Roche Ltd., FDNA(TM) INC, GeneDx, LLC, Illumina, Inc., Invitae Corporation, Novo Nordisk A/S, Quest Diagnostics, etc.

Polaris Market Research has segmented the global rare disease diagnostics market report based on disease type, product type, sample type, technology, test, age group, trait type, end-user, and region:

Global Rare Disease Diagnostics, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

Global Rare Disease Diagnostics, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

Global Rare Disease Diagnostics, Sample Type Outlook (Revenue - USD Million, 2019 - 2032)

Global Rare Disease Diagnostics, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

Global Rare Disease Diagnostics, Test Outlook (Revenue - USD Million, 2019 - 2032)

Global Rare Disease Diagnostics, Age Group Outlook (Revenue - USD Million, 2019 - 2032)

Global Rare Disease Diagnostics, Trait Type Outlook (Revenue - USD Million, 2019 - 2032)

Global Rare Disease Diagnostics, End- Use Outlook (Revenue - USD Million, 2019 - 2032)

Global Rare Disease Diagnostics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Stakeholders

3. Executive Summary

4. Research Methodology

5. Global Rare Disease Diagnostics Market Insights

6. Global Rare Disease Diagnostics Market, by Disease Type

7. Global Rare Disease Diagnostics Market, by Mode of Product Type

8. Global Rare Disease Diagnostics Market, by Sample Type

9. Global Rare Disease Diagnostics Market, by Technology

10. Global Rare Disease Diagnostics Market, by Test

11. Global Rare Disease Diagnostics Market, by Age Group

12. Global Rare Disease Diagnostics Market, by Trait Type

13. Global Rare Disease Diagnostics Market, by End-Use

14. Global Rare Disease Diagnostics Market, by Geography

15. Competitive Landscape

16. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â